Objective: This post hoc analysis investigates the effect of vortioxetine on cognitive
functioning and depressive symptoms in working adults with major depressive disorder …

Abstract Background Major Depressive Disorder (MDD) is a complex disease characterized
by emotional, physical and cognitive symptoms. We explored the efficacy of vortioxetine …

ObjectiveAtWoRC (Assessment in Work productivity and the Relationship with Cognitive
symptoms) was an interventional, open-label, Canadian study (NCT02332954) designed to …

Background: Management of cognitive deficits in Major Depressive Disorder (MDD) remains
an important unmet need. This meta-analysis evaluated the effects of vortioxetine on …

Abstract Background Major Depressive Disorder (MDD) is a heterogeneous disease
characterized by emotional, physical and cognitive symptoms. This study explored the …

Background The objectives of this meta‐analysis of data from randomized, placebo‐
controlled studies were to assess the effect of vortioxetine on overall functioning (primary) …

The efficacy of vortioxetine 10 and 20 mg/d vs. placebo on cognitive function and depression
in adults with recurrent moderate-to-severe major depressive disorder (MDD) was …

ABSTRACT Context: Vortioxetine (Lu AA21004) is an antidepressant with a mechanism of
action thought to be related to a combination of 2 pharmacologic actions: direct modulation …

ObjectiveThe Assessment in Work Productivity and the Relationship with Cognitive
Symptoms (AtWoRC) study aimed to assess the association between cognitive symptoms …

Background Dementia and depression are increasingly common worldwide, and their
effective control could ease the burden on economies, public health systems, and support …